Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Ranibizumab in Subjects With Dense Cataract and Rubeosis Due to Proliferative Diabetic Retinopathy (PDR)

NCT01069341 is registered in ClinicalTrials.gov with Bhagat, Neelakshi, M.D., M.P.H. as lead sponsor.

NCT NCT01069341
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01069341 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Ranibizumab in Subjects With Dense Cataract and Rubeosis Due to Proliferative Diabetic Retinopathy (PDR)
Lead sponsor
Bhagat, Neelakshi, M.D., M.P.H.
Phase
Phase 1
Overall status
Completed
Start date
July 31, 2007
Completion date
January 31, 2012
Enrollment
4 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

proliferative diabetic retinopathy, rubeosis iridis